Europe, Middle East & Africa Blood Glucose Test Strip market information by types (Glucose Oxidase, Glucose Dehydrogenase, Other), End User (Hospital, Clinic, Household), by technology (Wicking technology and Channel technology) and by region (Europe, Middle East and Africa) - Forecast to 2032

Table of Contents
1 Report Prologue

2 Market Introduction

2.1 Introduction

2.2 Scope of Study

2.3 Research Objective

2.4 Assumptions & Limitations

2.4.1 Assumptions

2.4.2 Limitations

3 Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

4 Market Dynamics

4.1 Drivers

4.1.1 Improving Medical Device Regulation

4.1.2 Growing incidence number of Diabetes

4.1.3 Increasing prevalence of diseases

4.1.4 Increasing inclination towards home healthcare

4.2 Restraints

4.2.1 Risk Associated with design, power and safety

5 Market Factor Analysis

5.1 Porter’s Five Forces Model

5.1.1 Bargaining power of suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Supply Chain Analysis

6 Europe, Middle East & Africa Blood Glucose Test Stripes Market, By Type

6.1 Glucose Oxidase

6.2 Glucose Dehydrogenase

6.3 Others

7 Europe, Middle East & Africa Blood Glucose Test Stripes Market, By End Users

7.1 Hospitals

7.2 Clinics

7.3 Homecare

8 Europe, Middle East & Africa Blood Glucose Test Stripes Market, By Technology

8.1 Wicking technology

8.2 Channel technology

9 Europe, Middle East & Africa Blood Glucose Test Stripes Market, By Regions

9.1 Europe

9.1.1 Germany

9.1.2 France

9.1.3 UK

9.1.4 Italy

9.1.5 Spain

9.1.6 Rest of Europe

9.2 Middle East & Africa

10 Competitive Landscape

10.1 Pricing of Medical Blood glucose test stripes

10.2 Production Capacity of Major Players

11 Company Profile

11.1 Abbott

11.1.1 Overview

11.1.2 Product/Business Segment Overview

11.1.3 Financial Updates

11.1.4 Key Developments

11.2 Ascensia Diabetes Care Holdings

11.2.1 Overview

11.2.2 Product/Business Segment Overview

11.2.3 Financial Updates

11.2.4 Key Developments

11.3 AgaMatrix

11.3.1 Overview

11.3.2 Product/Business Segment Overview

11.3.3 Financial Updates

11.3.4 Key Developments

11.4 ALL Medicus and Hainice Medical

11.4.1 Overview

11.4.2 Product/Business Segment Overview

11.4.3 Financial Updates

11.4.4 Key Developments

11.5 ARKRAY

11.5.1 Overview

11.5.2 Product/Business Segment Overview

11.5.3 Financial Updates

11.5.4 Key Developments

11.6 Braun

11.6.1 Overview

11.6.2 Product/Business Segment Overview

11.6.3 Financial Updates

11.6.4 Key Developments

11.7 Elektronika

11.7.1 Company Overview

11.7.2 Product/Business Segment Overview

11.7.3 Financial Updates

11.7.4 Key Development

11.8 LIFESCAN

11.8.1 Overview

11.8.2 Product/Business Segment Overview

11.8.3 Financial Overview

11.8.4 Key Development

11.9 I-SENS

11.9.1 Overview

11.9.2 Product/Business Segment Overview

11.9.3 Financial Overview

11.9.4 Key Development

11.10 Infopia

11.10.1 Overview

11.10.2 Product/Business Segment Overview

11.10.3 Financial Overview

11.10.4 Key Development

11.11 Nipro Diagnostics

11.11.1 Overview

11.11.2 Product/Business Segment Overview

11.11.3 Financial Overview

11.11.4 Key Development

11.12 Panasonic (Bayer)

11.12.1 Overview

11.12.2 Product/Business Segment Overview

11.12.3 Financial Overview

11.12.4 Key Development

11.13 Omron

11.13.1 Overview

11.13.2 Product/Business Segment Overview

11.13.3 Financial Overview

11.13.4 Key Development

11.14 Roche Diagnostics

11.14.1 Overview

11.14.2 Product/Business Segment Overview

11.14.3 Financial Overview

11.14.4 Key Development

11.15 Terumo

11.15.1 Overview

11.15.2 Product/Business Segment Overview

11.15.3 Financial Overview

11.15.4 Key Development

11.16 SANNUO

11.16.1 Overview

11.16.2 Product/Business Segment Overview

11.16.3 Financial Overview

11.16.4 Key Development

11.17 Others